Pathogenesis of Central Serous Choroidopathy: A Novel Hypothesis

Overview

Journal Indian J Ophthalmol

Specialty Ophthalmology

Date 2024 Sep 27

PMID 39331425

Authors

Rohan Chawla

Affiliations

Soon will be listed here.

References

Spaide R, Cheung C, Matsumoto H, Kishi S, Boon C, van Dijk E . Venous overload choroidopathy: A hypothetical framework for central serous chorioretinopathy and allied disorders. Prog Retin Eye Res. 2021; 86:100973. DOI: 10.1016/j.preteyeres.2021.100973. View

Han J, Hwang J, Kim J, Park K, Woo S . Changes in choroidal thickness after systemic administration of high-dose corticosteroids: a pilot study. Invest Ophthalmol Vis Sci. 2013; 55(1):440-5. DOI: 10.1167/iovs.13-12854. View

Daruich A, Matet A, Dirani A, Bousquet E, Zhao M, Farman N . Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis. Prog Retin Eye Res. 2015; 48:82-118. DOI: 10.1016/j.preteyeres.2015.05.003. View

Bousquet E, Beydoun T, Zhao M, Hassan L, Offret O, Behar-Cohen F . Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: a pilot study. Retina. 2013; 33(10):2096-102. DOI: 10.1097/IAE.0b013e318297a07a. View

Reiner A, Fitzgerald M, Del Mar N, Li C . Neural control of choroidal blood flow. Prog Retin Eye Res. 2017; 64:96-130. PMC: 5971129. DOI: 10.1016/j.preteyeres.2017.12.001. View

Bill A, Sperber G . Control of retinal and choroidal blood flow. Eye (Lond). 1990; 4 ( Pt 2):319-25. DOI: 10.1038/eye.1990.43. View

Mebrahtu T, Morgan A, West R, Stewart P, Pujades-Rodriguez M . Oral glucocorticoids and incidence of hypertension in people with chronic inflammatory diseases: a population-based cohort study. CMAJ. 2020; 192(12):E295-E301. PMC: 7101178. DOI: 10.1503/cmaj.191012. View

Tittl M, Maar N, Polska E, Weigert G, Stur M, Schmetterer L . Choroidal hemodynamic changes during isometric exercise in patients with inactive central serous chorioretinopathy. Invest Ophthalmol Vis Sci. 2005; 46(12):4717-21. DOI: 10.1167/iovs.05-0268. View

Eom Y, Oh J, Kim S, Huh K . Systemic factors associated with central serous chorioretinopathy in Koreans. Korean J Ophthalmol. 2012; 26(4):260-4. PMC: 3408530. DOI: 10.3341/kjo.2012.26.4.260. View

10.

Fung A, Yang Y, Kam A . Central serous chorioretinopathy: A review. Clin Exp Ophthalmol. 2023; 51(3):243-270. DOI: 10.1111/ceo.14201. View

11.

Wang W, He M, Zhong X . Sex-Dependent Choroidal Thickness Differences in Healthy Adults: A Study Based on Original and Synthesized Data. Curr Eye Res. 2018; 43(6):796-803. DOI: 10.1080/02713683.2018.1428995. View

12.

Mihara N, Funatsu R, Sonoda S, Shiihara H, Sakono T, Sakamoto T . Sex differences in choroidal vessels using novel wide-field choroidal en-face images from optical coherence tomography. Sci Rep. 2024; 14(1):17013. PMC: 11266693. DOI: 10.1038/s41598-024-67671-w. View

13.

Venkatesh P, Chawla R, Tripathy K, Singh H, Bypareddy R . Scleral resection in chronic central serous chorioretinopathy complicated by exudative retinal detachment. Eye Vis (Lond). 2016; 3(1):23. PMC: 5016948. DOI: 10.1186/s40662-016-0055-5. View

14.

Carvalho-Recchia C, Yannuzzi L, Negrao S, Spaide R, Freund K, Rodriguez-Coleman H . Corticosteroids and central serous chorioretinopathy. Ophthalmology. 2002; 109(10):1834-7. DOI: 10.1016/s0161-6420(02)01117-x. View

15.

Ullian M . The role of corticosteriods in the regulation of vascular tone. Cardiovasc Res. 1999; 41(1):55-64. DOI: 10.1016/s0008-6363(98)00230-2. View

16.

Feenstra H, van Dijk E, Cheung C, Ohno-Matsui K, Lai T, Koizumi H . Central serous chorioretinopathy: An evidence-based treatment guideline. Prog Retin Eye Res. 2024; 101:101236. DOI: 10.1016/j.preteyeres.2024.101236. View

17.

Yannuzzi L . Type-A behavior and central serous chorioretinopathy. Retina. 1987; 7(2):111-31. DOI: 10.1097/00006982-198700720-00009. View

18.

Matsumoto H, Hoshino J, Mukai R, Nakamura K, Kikuchi Y, Kishi S . Vortex Vein Anastomosis at the Watershed in Pachychoroid Spectrum Diseases. Ophthalmol Retina. 2020; 4(9):938-945. DOI: 10.1016/j.oret.2020.03.024. View

19.

Behera U, Brar A, Kelgaonkar A, Sahoo J, Narayanan R, Sadda S . Efficacy of dexamethasone implant in the management of chronic central serous chorioretinopathy without choroidal neovascularization. Indian J Ophthalmol. 2024; 73(Suppl 1):S100-S106. PMC: 11834931. DOI: 10.4103/IJO.IJO_626_24. View

20.

Cardillo Piccolino F, Fruttini D, Eandi C, Nicolo M, Mariotti C, Tito S . Vigorous Physical Activity as a Risk Factor for Central Serous Chorioretinopathy. Am J Ophthalmol. 2022; 244:30-37. DOI: 10.1016/j.ajo.2022.08.002. View